These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21818280)

  • 21. Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
    Li H; Liu Y; Gong P; Zhang C; Ye J;
    PLoS One; 2014; 9(1):e82450. PubMed ID: 24416143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel approach to brain connectivity reveals early structural changes in Alzheimer's disease.
    La Rocca M; Amoroso N; Monaco A; Bellotti R; Tangaro S
    Physiol Meas; 2018 Jul; 39(7):074005. PubMed ID: 29943735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns.
    Wee CY; Yap PT; Shen D;
    Hum Brain Mapp; 2013 Dec; 34(12):3411-25. PubMed ID: 22927119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI.
    Chen Z; Chen K; Li Y; Geng D; Li X; Liang X; Lu H; Ding S; Xiao Z; Ma X; Zheng L; Ding D; Zhao Q; Yang L;
    Hum Brain Mapp; 2024 Jan; 45(1):e26529. PubMed ID: 37991144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Alzheimer's Disease and Mild Cognitive Impairment Using Networks Constructed Based on Multiple Morphological Brain Features.
    Zheng W; Yao Z; Xie Y; Fan J; Hu B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Oct; 3(10):887-897. PubMed ID: 30077576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ensemble of convolutional neural networks and multilayer perceptron for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Li M; Jiang Y; Li X; Yin S; Luo H
    Med Phys; 2023 Jan; 50(1):209-225. PubMed ID: 36121183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation-Weighted Sparse Group Representation for Brain Network Construction in MCI Classification.
    Yu R; Zhang H; An L; Chen X; Wei Z; Shen D
    Med Image Comput Comput Assist Interv; 2016 Oct; 9900():37-45. PubMed ID: 28642938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using deep Siamese neural networks for detection of brain asymmetries associated with Alzheimer's Disease and Mild Cognitive Impairment.
    Liu CF; Padhy S; Ramachandran S; Wang VX; Efimov A; Bernal A; Shi L; Vaillant M; Ratnanather JT; Faria AV; Caffo B; Albert M; Miller MI; ;
    Magn Reson Imaging; 2019 Dec; 64():190-199. PubMed ID: 31319126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF and brain structural imaging markers of the Alzheimer's pathological cascade.
    Yang X; Tan MZ; Qiu A
    PLoS One; 2012; 7(12):e47406. PubMed ID: 23284610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-stage renal disease accompanied by mild cognitive impairment: A study and analysis of trimodal brain network fusion.
    Chen J; Liu T; Shi H
    PLoS One; 2024; 19(6):e0305079. PubMed ID: 38870175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
    J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.
    Li Y; Wang Y; Wu G; Shi F; Zhou L; Lin W; Shen D;
    Neurobiol Aging; 2012 Feb; 33(2):427.e15-30. PubMed ID: 21272960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.
    Zhang Y; Schuff N; Camacho M; Chao LL; Fletcher TP; Yaffe K; Woolley SC; Madison C; Rosen HJ; Miller BL; Weiner MW
    PLoS One; 2013; 8(6):e66367. PubMed ID: 23762488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.
    Eskildsen SF; Coupé P; García-Lorenzo D; Fonov V; Pruessner JC; Collins DL;
    Neuroimage; 2013 Jan; 65():511-21. PubMed ID: 23036450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.